ERErica Rutherford

Erica Rutherford

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erica Rutherford has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A collaborative submission model for building high-quality data resources at scale through partnership: lessons from single-cell genomics

    by Jason A. Hilton, Jim Chaffer, Jennifer Chien, Idan Gabdank, Brian Mott, Erica Rutherford, Corinn Small, Jennifer Zamanian, Brian Aevermann, J. Michael Cherry, et al.

    Community data resources that aggregate datasets across studies are critical infrastructure for modern biomedical research, accelerating discovery, and rapidly-advancing Artificial Intelligence (AI) models place ever-greater demand on large, well-described data corpora. However, building these resources involves a fundamental tension: comprehensive metadata is imperative for reuse, yet capturing this information systematically requires substantial effort that limits growth. We detail how CZ CELLxGENE Discover has used a collaborative submission model, whereby data contributors partner with dedicated resource curators, to become a large, widely used single-cell genomics resource for diverse analytical applications including AI model development and integrative analysis. This partnership leverages contributors’ intimate study knowledge and curators’ focus on data reuse and expertise in standardization to improve data quality, metadata accuracy, and richness. This is achieved by motivating researcher participation through tangible benefits while minimizing submission burden. We contrast this collaborative model with contributor-driven and resource-driven approaches, highlighting tradeoffs in scalability, consistency across submissions, and quality assurance. The principles and practices we describe provide a framework for building high-quality community data resources across diverse biological data types.


  • Open Access

    CZ CELL×GENE Discover: A single-cell data platform for scalable exploration, analysis and modeling of aggregated data

    by Czi Single-Cell Biology Program, Shibla Abdulla, Brian Aevermann, Pedro Assis, Seve Badajoz, Sidney M. Bell, Emanuele Bezzi, Batuhan Cakir, Jim Chaffer, Signe Chambers, et al.

    Hundreds of millions of single cells have been analyzed to date using high throughput transcriptomic methods, thanks to technological advances driving the increasingly rapid generation of single-cell data. This provides an exciting opportunity for unlocking new insights into health and disease, made possible by meta-analysis that span diverse datasets building on recent advances in large language models and other machine learning approaches. Despite the promise of these and emerging analytical tools for analyzing large amounts of data, a major challenge remains the sheer number of datasets and inconsistent format, data models and accessibility. Many datasets are available via unique portals platforms that often lack interoperability. Here, we present CZ CellxGene Discover ( cellxgene.cziscience.com ), a data platform that provides curated and interoperable data. This single-cell data resource, available via a free-to-use online data portal, hosts a growing corpus of community contributed data that spans more than 50 million unique cells. Curated, standardized, and associated with consistent cell-level metadata, this collection of interoperable single-cell transcriptomic data is the largest of its kind. A suite of tools and features enables accessibility and reusability of the data via both computational and visual interfaces to allow researchers to rapidly explore individual datasets and perform cross-corpus analysis. This functionality is enabling meta-analyses of tens of millions of cells across studies and tissues and providing global views of human cells at the resolution of single cells.


  • 1023P A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed death protein-1 (PD-1) therapy

    by H. Kiefel, D. Haria, J.D. Ravichandar, J. Desnoyer, J. Guagua, S. Lau, J. Lee, E. Rutherford, K. Dabbagh, P. Lal